AfreenIdrisShariffMD

Diabetes, Lipid Metabolism

Physician

Dr. Shariff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4420 Lake Boone Trl
Raleigh, NC 27607
Phone+1 919-784-7093

Fax+1 919-784-7395

Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine, 2011 - 2014
Deccan College of Medical Sciences NTRClass of 2008

PubMed

Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy.
Randol Kennedy, Calvin Rei L Macrohon, Mary Lourdes Grace V David, Meg Lee, April K S Salama
JCEM Case Reports. 2025-03-01
Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.
Anupam Kotwal, Randol Kennedy, Nupur Kikani, Sonali Thosani, Whitney Goldner
Endocrine Practice. 2024-06-01
6 citations
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner
Journal for Immunotherapy of Cancer. 2024-04-10

Diabetics Rationing Insulin Amid High Costs: StudyOctober 20th, 2022
Researchers Point to Toxic Side Effects of Cancer Drugs | SciencesSeptember 8th, 2022
Researchers Take Aim at Cancer Drugs’ Toxic Side EffectsAugust 31st, 2022